All contracts › District of Columbia

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

In plain English

The Biomedical Advanced Research and Development Authority (BARDA) wants contractors to make vaccines and related materials for pandemic influenza preparedness and response, and to generate data for the Food and Drug Administration (FDA). Bidders must have a U.S. influenza vaccine license or a submitted Biologics License Application (BLA). Details are in attachments.

Agency: Health And Human Services, Department Of · Office Of Assistant Secretary For Preparedness And Response
Notice type: Solicitation
Set-aside: No set-aside (open to all)
NAICS: 541714
Place of performance: Washington, DC
Posted: Oct 26, 2026
Response due: Nov 20, 2026
Solicitation number: 75A50126R00001_RFP_NPIVS_27

Open on SAM.gov

Description

BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.

Get only the ones that fit you, every morning.

Yia | Contract Alerts reads every new notice and emails you the matches for your NAICS codes, location and certifications, each with a fit score. 14-day free trial.

Start free